Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide

International Journal of Pharmaceutics

Volumn 325, Issue 1-2, 2006, Pages 82-89

  Woolfson, A David ^a   Malcolm, R Karl ^a   Morrow, Ryan J ^a   Toner, Clare F ^a   McCullagh, Stephen D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

HIV AIDS; Intravaginal ring; Microbicide; Reverse transcriptase; TMC 120

Indexed keywords

DAPIVIRINE; DIMETICONE; LACTOSE; MICROBICIDE; MYRISTIC ACID ISOPROPYL ESTER; RNA DIRECTED DNA POLYMERASE INHIBITOR; SILICONE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG FORMULATION; HUMAN IMMUNODEFICIENCY VIRUS; HYDROPHILICITY; HYDROPHOBICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STEADY STATE; VAGINA RING;

ADMINISTRATION, INTRAVAGINAL; CONTRACEPTIVE DEVICES, FEMALE; DELAYED-ACTION PREPARATIONS; DIFFUSION; DIMETHYLPOLYSILOXANES; EQUIPMENT DESIGN; EQUIPMENT SAFETY; EXCIPIENTS; FEMALE; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; HYDROPHOBICITY; KINETICS; LACTOSE; MOLECULAR STRUCTURE; MYRISTATES; NYLONS; PERMEABILITY; PYRIMIDINES; SILICONE ELASTOMERS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS;

EID: 33750012577     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.06.026     Document Type: Article

References (25)

1. Ballagh S.A. Vaginal Ring Hormone Delivery System. Clin. Obstet. Gynecol. 44 (2001) 106-113
2. Carelli V., and Di Colo G. Effect of different water-soluble additives on water sorption into silicone rubber. J. Pharm. Sci. 72 (1983) 316-317
3. Chia S.E., Tay S.K., and Lim S.T. What constitutes a normal seminal analysis? Semen parameters of 243 fertile men. Human Reprod. 13 (1998) 3394-3398
4. Chien Y.W. Novel Drug Delivery Systems. 2nd ed. (1992), Marcel Dekker, New York pp. 47-50
5. Di Colo G. Controlled drug release from implantable matrices based on hydrophobic polymers. Biomaterials 13 (1992) 850-856
6. Di Fabio S., Van Roey J., Giannini G., van den Mooter G., Spada M., Binelli A., Pirillo M.F., Germinario E., Belardelli F., de Bethune M.P., and Vella S. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS 17 (2003) 1597-1604
7. Gruzdev B., Horban A., Boron-Kaczmarska A., Gille D., van't Klooster G., and Pauwels R. TMC120, a new non-nucleoside reverse transcriptase inhibitor, is a potent antiretroviral in treatment of naive, HIV-1 infected subjects. Proceedings of the Eighth Conference on Retroviruses and Opportunistic Infections. Chicago (2001) Abstract No. 13
8. Herrewege Y.V., Michiels J., Van Roey J., Fransen K., Kestens L., Balzarini J., Lewi P., Vanham G., and Janssen P. In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrob. Agents Chemother. 48 (2004) 337-399
9. Hseih D.S.T., and Chien Y.W. Enhanced release of drugs from silicone elastomers (II): induction of swelling and changes in microstructure. Drug Dev. Ind. Pharm. 11 (1985) 1411-1432
10. Johansson E.D.B., and Sitruk-Ware R. New delivery systems in contraception: vaginal rings. Am. J. Obstet. Gynecol. 190 (2004) S54-S59
11. Kajihara M., Sugie T., Sano A., Fujioka K., Urabe Y., Tanihara M., and Imanishi Y. Novel method to control release of lipophilic drugs with high potency from silicone. Chem. Pharm. Bull. 51 (2003) 11-14
12. Malcolm K., and Woolfson D. Blocking heterosexual transmission of HIV: intravaginal rings for the controlled delivery of topical microbicides. Drug Deliv. Syst. Sci. 1 (2001) 117-121
13. Malcolm R.K. The intravaginal ring. In: Rathbone M.J., Hadgraft J., and Roberts M.S. (Eds). Modified Release Drug Delivery Technology (2003), Marcel Dekker, New York 775-790
14. Malcolm K., Woolfson D., Russell J., and Andrews C. In vitro release of nonoxynol-9 from silicone matrix intravaginal rings. J. Control. Rel. 91 (2003) 355-364
15. Malcolm K., Woolfson D., Toner C., and Lowry D. Vaginal microbicides for the prevention of HIV transmission. Biotechnol. Genet. Eng. Rev. 21 (2004) 81-121
16. Malcolm R.K., Woolfson A.D., Toner C., Morrow R.J., and McCullagh S.D. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. J. Antimicrob. Chemother. 56 (2005) 954-956
17. Moore J.P., and Shattock R.J. Preventing HIV-1 sexual transmission-not sexy enough science, or no benefit to the bottom line?. J. Antimicrob. Chemother. 52 (2003) 890-892
18. Owen D.H., and Katz D.F. A vaginal fluid simulant. Contraception 59 (1999) 91-95
19. Rehula M., and Di Colo G. In vitro release of papaverine hydrochloride from silicone polymer matrices containing cross-linked polyethylene glycol 800. Pharmazie 48 (1993) 36-42
20. Riggs P.D., Parker S., Braden M., and Kalachandra S. Influence of additives on the water uptake of hydrosilanized silicone rubbers. Biomaterials 18 (1997) 721-726
21. Shattock R.J., and Moore J.P. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1 (2003) 25-34
22. Shattock R.J., and Solomon S. Microbicides-aids to safer sex. Lancet 363 (2004) 1002-1003
23. Stone A. Microbicides: a new approach to preventing HIV and other sexually transmitted infections. Nat. Rev. Drug Discov. 1 (2002) 977-985
24. Tibotec Pharmaceuticals Ltd., 2004. Belgium, Unpublished data.
25. Woolfson A.D., Malcolm R.K., and Gallagher R.J. Drug delivery by the intravaginal route. Crit. Rev. Ther. Drug Carr. Syst. 17 (2000) 509-555